Improvement Of Trispecific Antibodies To HIV-1 By Engraftment Of The FR3 Loop Of VRC03 (FR3-03)
US Application 62/831,415
Filed on 2019-04-09
Filed on 2019-04-09
EPSTEIN-BARR VIRUS MONOCLONAL ANTIBODIES AND USES THEREOF
US Application 62/979,070
Filed on 2020-02-20
Filed on 2020-02-20
COMPOSITIONS INCLUDING IGG Fe MUTATIONS AND USES THEREOF
US Application 62/894,488
Filed on 2019-08-30
Filed on 2019-08-30
STABILIZED NOROVIRUS VIRUS-LIKE PARTICLES AS VACCINE IMMUNOGENS
US Application 63/091,824
Filed on 2020-10-14
Filed on 2020-10-14
MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE
US Application 62/946,902
Filed on 2019-12-11
Filed on 2019-12-11
NON-NEUTRALIZING ANTIBODIES ELICITED BY RECOMBINANT LASSA-RABIES VACCINE ARE CRITICAL FOR PROTECTION AGAINST LASSA FEVER
US Application 62/691,413
Filed on 2018-06-28
Filed on 2018-06-28
RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE
US Application 63/017,581
Filed on 2020-04-29
Filed on 2020-04-29
Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response
US Application 62/617,519
Filed on 2018-01-15
Filed on 2018-01-15
HIV RNA VACCINES
US Application 62/819,394
Filed on 2019-03-15
Filed on 2019-03-15
NHIV-Specific CD8+ T Cell Receptors From Long-Term Nonprogressors/Elite Controllers
US Application 62/792,880
Filed on 2019-01-15
Filed on 2019-01-15